Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Publisher Correction: Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies.

Shaw A, Hoffecker IT, Smyrlaki I, Rosa J, Grevys A, Bratlie D, Sandlie I, Michaelsen TE, Andersen JT, Högberg B.

Nat Nanotechnol. 2019 Apr;14(4):398. doi: 10.1038/s41565-019-0404-3.

PMID:
30783200
2.

Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies.

Shaw A, Hoffecker IT, Smyrlaki I, Rosa J, Grevys A, Bratlie D, Sandlie I, Michaelsen TE, Andersen JT, Högberg B.

Nat Nanotechnol. 2019 Feb;14(2):184-190. doi: 10.1038/s41565-018-0336-3. Epub 2019 Jan 14. Erratum in: Nat Nanotechnol. 2019 Feb 19;:.

3.

Human Secretory IgM Antibodies Activate Human Complement and Offer Protection at Mucosal Surface.

Michaelsen TE, Emilsen S, Sandin RH, Granerud BK, Bratlie D, Ihle O, Sandlie I.

Scand J Immunol. 2017 Jan;85(1):43-50. doi: 10.1111/sji.12508.

4.

Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.

Giuntini S, Granoff DM, Beernink PT, Ihle O, Bratlie D, Michaelsen TE.

Clin Vaccine Immunol. 2016 Aug 5;23(8):698-706. doi: 10.1128/CVI.00193-16. Print 2016 Aug.

5.

Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.

Grevys A, Bern M, Foss S, Bratlie DB, Moen A, Gunnarsen KS, Aase A, Michaelsen TE, Sandlie I, Andersen JT.

J Immunol. 2015 Jun 1;194(11):5497-508. doi: 10.4049/jimmunol.1401218. Epub 2015 Apr 22.

6.

A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.

Vestrheim AC, Moen A, Egge-Jacobsen W, Reubsaet L, Halvorsen TG, Bratlie DB, Paulsen BS, Michaelsen TE.

Immun Inflamm Dis. 2014 Aug;2(2):76-91. doi: 10.1002/iid3.22. Epub 2014 May 22.

7.

Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.

Vestrheim AC, Moen A, Egge-Jacobsen W, Bratlie DB, Michaelsen TE.

Scand J Immunol. 2013 May;77(5):419-28. doi: 10.1111/sji.12046. Erratum in: Scand J Immunol. 2013 Jul;78(1):108-10.

8.

Structural difference in the complement activation site of human IgG1 and IgG3.

Michaelsen TE, Sandlie I, Bratlie DB, Sandin RH, Ihle O.

Scand J Immunol. 2009 Dec;70(6):553-64. doi: 10.1111/j.1365-3083.2009.02338.x.

Supplemental Content

Loading ...
Support Center